Inactive/Delisted stock

Generation Bio Stock (NASDAQ:GBIO)

Chart

Previous Close

$0.34

52W Range

$0.30 - $3.65

50D Avg

$0.39

200D Avg

$1.06

Market Cap

$23.73M

Avg Vol (3M)

$704.65K

Beta

2.66

Div Yield

GBIO Company Profile

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

Country

Employees

115

IPO Date

Jun 12, 2020

Website

GBIO Performance

Total Return %

YTD

10Y

GBIO

S&P 500

4.76%

-4.32%

-8.62%

-4.97%

-69.22%

-68.11%

-83.61%

-94.99%

-98.20%

-98.57%

0.74%

1.99%

4.89%

23.70%

5.59%

6.91%

12.69%

63.64%

97.15%

202.37%

Peer Comparison

Ticker	Company
MLYS	Mineralys Therapeutics, Inc.
KZR	Kezar Life Sciences, Inc.
ORIC	ORIC Pharmaceuticals, Inc.
KROS	Keros Therapeutics, Inc.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools